1323271-65-3

Upstream product

• 1323271-61-9 C₁₉H₃₄O₉ 
• 90-80-2 D-Glucono-1,5-lactone 
• 1323271-55-1 C₁₈H₃₄O₁₀ 

Downstream Products

• 857633-06-8 7-O-acetyl-streptol 
• 1323271-75-5 C₁₉H₃₈O₉ 
• 94943-08-5 (1S)-(+)-(1,3/2,4,5)-2,3,4,5-tetrahydroxycyclohexanemethanol 
• 111136-25-5 α-valienol 
• 1449602-81-6 C₂₁H₂₄O₆ 
• 1449602-82-7 C₃₃H₅₀O₁₀ 
• 1449602-84-9 C₃₃H₅₀O₁₀ 
• 1449602-85-0 C₂₁H₂₆O₆ 
• 1449602-87-2 C₂₁H₂₆O₆ 
• 1449602-83-8 C₂₁H₂₆O₆ 
• 1449602-77-0 C₁₉H₃₅ClO₈ 
• 1449602-78-1 C₃₃H₄₈O₁₀ 
• 875111-55-0 (1R,2S,3R,6R)-4-hydroxymethyl-6-[2-(4-methoxybenzyl)-phenoxy]cyclohex-4-ene-1,2,3-triol 
• 1449602-80-5 C₃₃H₄₈O₁₀ 

Relevant academic research and scientific papers

NOVEL COMPOUNDS FOR TREATING DIABETES

The present invention provides a class of novel aryl pseudo-C-glycoside compounds that are effective for treating diabetes. Also provided are methods for making such compounds and methods for treating diabetes by administering such compounds to patients w

Short and efficient syntheses of gabosine I, streptol, 7-O-acetylstreptol, 1-epi-streptol, gabosine K, and carba α-d-glucose from δ-d-gluconolactone

δ-d-Gluconolactone was carbocyclized into an EOM-protected cyclohexenone in four steps involving perethoxymethylation, phosphonate anion addition, reduction, and oxidation with concomitant Horner-Wadsworth-Emmons alkenation. The stable key enone was effic